Single photon emission computed tomography and statistical parametric mapping analysis in cirrhotic patients with and without minimal hepatic encephalopathy

Annals of Nuclear Medicine

Volumn 18, Issue 2, 2004, Pages 123-129

  Nakagawa, Yuri ^a   Matsumura, Kaname ^a   Iwasa, Motoh ^a   Kaito, Masahiko ^a   Adachi, Yukihiko ^a   Takeda, Kan ^a  

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cerebral blood flow; Cingulate; Hepatic encephalopathy; Liver cirrhosis; Single photon emission computed tomography

Indexed keywords

CYSTEINE ETHYL ESTER TC 99M;

ADULT; AGED; ARTICLE; BRAIN BLOOD FLOW; BRAIN PERFUSION; CINGULATE GYRUS; CLINICAL ARTICLE; COGNITIVE DEFECT; DAILY LIFE ACTIVITY; DIAGNOSTIC IMAGING; DISEASE SEVERITY; FEMALE; FRONTAL LOBE; HEMOPERFUSION; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER CIRRHOSIS; MALE; NEUROPSYCHOLOGICAL TEST; PARAMETRIC TEST; PARIETAL LOBE; PREMOTOR CORTEX; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STATISTICAL ANALYSIS; STATISTICAL PARAMETRIC MAPPING ANALYSIS;

EID: 3042800195     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02985102     Document Type: Article

References (28)

1. 99mTc-HM-PAO single-photon emission computed tomography: effect of liver transplantation. J Hepatol 1998; 29: 78-84.
2. Catafau AM, Kulisevsky J, Bernà L, Pujol J, Martin JC, Otermin P, et al. Relationship between cerebral perfusion in frontal-limbic-basal ganglia circuits and neuropsychologic impairment in patients with subclinical hepatic encephalopathy. J Nucl Med 2000; 41: 405-410.
3. Lockwood AH, Weissenborn K, Bokemeyer M, Tietge U, Burchert W. Correlations between cerebral glucose metabolism and neuropsychological test performance in nonalcoholic cirrhotics. Metab Brain Dis 2002; 17: 29-40.
4. Lockwood AH, Yap EW, Rhoades HM, Wong WH. Altered cerebral blood flow and glucose metabolism in patients with liver disease and minimal encephalopathy. J Cereb Blood Flow Metab 1991; 11: 331-336.
5. O'Carroll RE, Hayes PC, Ebmeier KP, Dougall N, Murray C, Best JJ, et al. Regional cerebral blood flow and cognitive function in patients with chronic liver disease. Lancet 1991; 337: 1250-1253.
6. Trzepacz PT, Tarter RE, Shah A, Tringali R, Faett DG, Van Thiel DH. SPECT scan and cognitive findings in subclinical hepatic encephalopathy. J Neuropsychiatry Clin Neurosci 1994; 6: 170-175.
7. Iwasa M, Matsumura K, Kaito M, Ikoma J, Kobayashi Y, Nakagawa N, et al. Decrease of regional cerebral blood flow in liver cirrhosis. Eur J Gastroenterol Hepatol 2000; 12: 1001-1006.
8. Brett M, Johnsrude IS, Owen AM. The problem of functional localization in the human brain. Nat Rev Neurosci 2002; 3: 243-249.
9. Friston KJ, Holmes AP, Worsley KJ, Poline JP, Frith CD, Frackowiak RSJ. Statistical parametric maps in functional imaging: a general linear approach. Hum Brain Mapping 1995; 2: 189-210.
10. Friston KJ, Ashburner J, Frith CD, Poline JB, Heather JD, Frackowiak RSJ. Spatial realignment and normalization of images. Hum Brain Mapping 1995; 2: 165-189.
11. Imon Y, Matsuda H, Ogawa M, Kogure D, Sunohara N. SPECT image analysis using statistical parametric mapping in patients with Parkinson's disease. J Nucl Med 1999; 40: 1583-1589.
12. Kogure D, Matsuda H, Ohnishi T, Asada T, Uno M, Kunihiro T, et al. Longitudinal evaluation of early Alzheimer's disease using brain perfusion SPECT. J Nucl Med 2000; 41: 1155-1162.
13. Stamatakis EA, Glabus MF, Wyper DJ, Barnes A, Wilson JT. Validation of statistical parametric mapping (SPM) in assessing cerebral lesions: a simulation study. Neuroimage 1999; 10: 397-407.
14. Stamatakis EA, Wilson JT, Hadley DM. SPECT imaging in head injury interpreted with statistical parametric mapping. J Nucl Med 2002; 43: 476-483.
15. Posner MI, Petersen SE. The attention system of the human brain. Annu Rev Neurosci 1990; 13: 25-42.
16. Posner MI. Attention in cognitive neuroscience: An overview. The cognitive neurosciences. Gazzaniga MS. Cambridge Massachusetts; MIT Press, 1995: 615-624.
17. Goldman-Rakic PS. Topography of cognition: parallel distributed networks in primate association cortex. Annu Rev Neurosci 1988; 11: 137-156.
18. Asenbaum S, Brücke T, Pirker W, Pietrzyk U, Podreka I. Imaging of cerebral blood flow with technetium-99m-HMPAO and technetium-99m-ECD: a comparison. J Nucl Med 1998; 39: 613-618.
19. 99mTc-HMPAO in the same brains: analysis by statistical parametric mapping. Eur J Nucl Med 2001; 28: 191-197.
20. Oku N, Matsumoto M, Hashikawa K, Moriwaki H, Ishida M, Seike Y, et al. Intra-individual differences between technetium-99m-HMPAO and technetium-99m-ECD in the normal medial temporal lobe. J Nucl Med 1997; 38: 1109-1111.
21. Tsuchida T, Nishizawa S, Yonekura Y, Sadato N, Iwasaki Y, Fujita T, et al. SPECT images of technetium-99m-ethyl cysteinate dimer in cerebrovascular diseases: comparison with other cerebral perfusion tracers and PET. J Nucl Med 1994; 35: 27-31.
22. Lockwood AH, Murphy BW, Donnelly KZ, Mahl TC, Perini S. Positron-emission tomographic localization of abnormalities of brain metabolism in patients with minimal hepatic encephalopathy. Hepatology 1993; 18: 1061-1068.
23. Mathew RJ, Wilson WH. Substance abuse and cerebral blood flow. Am J Psychiatry 1991; 148: 292-305.
24. Melgaard B, Henriksen L, Ahlgren P, Danielsen UT, Sorensen H, Paulson OB. Regional cerebral blood flow in chronic alcoholics measured by single photon emission computerized tomography. Acta Neurol Scand 1990; 82: 87-93.
25. Nicolás JM, Catafau AM, Estruch R, Lomena FJ, Salamero M, Herranz R, et al. Regional cerebral blood flow-SPECT in chronic alcoholism: relation to neuropsychological testing. J Nucl Med 1993; 34: 1452-1459.
26. Tarter RE, Edwards KI, Van Thiel DH. Neuropsychological dysfunction due to liver disease. Medical neuropsychology: the impact of disease on behavior. Tarter RE, Van Thiel DH, Edwards KI. New York; Plenum, 1988: 75-97.
27. Dunk AA, Moore JW. Cognitive dysfunction in latent portasystemic encephalopathy. Developments in clinical and experimental neuropsychology. Crawford JR, Parker DM. London; Plenum, 1989: 39-46.
28. Watanabe A, Sakai T, Sato S, Imai F, Ohto M, Arakawa Y, et al. Clinical efficacy of lactulose in cirrhotic patients with and without subclinical hepatic encephalopathy. Hepatology 1997; 26: 1410-1414.